Table 5.
Geometric mean fold-rise of titers after vaccination.
| NOR-201 | NOR-210 | Both | |
|---|---|---|---|
| GI.1 (1968) | 13.5 (7.8–23.3) | 14.4 (7.6–27.5) | 14.0 (9.3–20.9) |
| GI.2 (2013) | 2.3 (1.5–3.8) | 2.7 (1.6–4.5) | 2.5 (1.8–3.5) |
| GI.3 (2007) | 1.4 (1.1–1.9) | 1.6 (1.2–2.2) | 1.5 (1.3–1.9) |
| GI.4 (2008) | 2.3 (1.3–3.9) | 1.9 (1.3–2.9) | 2.1 (1.5–2.9) |
| GI.5 (2013) | 9.2 (5.0–17.2) | 6.1 (3.3–11.2) | 7.5 (4.9–11.5) |
| GI.6 (2003) | 6.9 (3.8–12.6) | 4.9 (2.9–8.2) | 5.8 (4.0–8.6) |
| GI.7 (2010) | 2.5 (1.6–4.0) | 2.8 (1.8–4.5) | 2.7 (1.9–3.7) |
| GII.3 (2011) | 1.7 (1.3–2.3) | 1.9 (1.2–3.2) | 1.8 (1.4–2.4) |
| GII.4 (CN) | 7.2 (4.4–11.9) | 19.7 (10.3–37.5) | 11.8 (7.8–17.9) |
| GII.4 (2002) | 6.4 (3.9–10.6) | 12.7 (7.5–21.4) | 9.0 (6.2–12.9) |
| GII.4 (2006a) | 6.0 (3.6–9.8) | 13.1 (7.7–22.3) | 8.7 (6.0–12.7) |
| GII.4 (2006b) | 5.8 (3.3–10.0) | 7.9 (4.7–13.3) | 6.7 (4.7–9.7) |
| GII.4 (2009) | 3.8 (2.3–6.1) | 5.3 (2.9–9.8) | 4.5 (3.1–6.5) |
| GII.4 (2012) | 5.0 (2.8–8.8) | 8.5 (5.2–14.0) | 6.5 (4.5–9.4) |
| GII.6 (2012) | 1.5 (1.2–1.9) | 1.7 (1.2–2.4) | 1.6 (1.3–2.0) |
| GII.12 (2010) | 1.4 (1.1–1.7) | 1.7 (1.2–2.3) | 1.5 (1.3–1.9) |
| GII.17 (1978) | 2.3 (1.6–3.3) | 2.8 (1.9–4.0) | 2.5 (2.0–3.3) |
| GII.17 (2014) | 2.0 (1.4–2.7) | 1.6 (1.1–2.2) | 1.8 (1.4–2.2) |
| GII.17 (2015) | 2.1 (1.5–2.9) | 1.9 (1.3–2.6) | 2.0 (1.6–2.5) |
| GIV.1 (2012) | 1.1 (0.9–1.3) | 1.1 (0.9–1.3) | 1.1 (1.0–1.2) |